A growing number of clinical studies focusing on probiotics is seen in Asia, with China and Iran seeing exponential increase in recent years, according to an International Probiotics Association-backed review.
A recent article in the Wall Street Journal has caused consternation among stakeholders in the probiotics space. Why? Well, for an article written by an MD and cancer researcher it’s as unscientific as it is potentially damaging.
The personalized nutrition revolution holds huge potential for the dietary supplement industry. But matching promises to performance will be the key to keeping that goose alive until it can deliver the golden eggs.